nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.671	1	CbGbCtD
Zidovudine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00721	0.0338	CcSEcCtD
Zidovudine—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0323	CcSEcCtD
Zidovudine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0302	CcSEcCtD
Zidovudine—Mania—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0264	CcSEcCtD
Zidovudine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0249	CcSEcCtD
Zidovudine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0192	CcSEcCtD
Zidovudine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0182	CcSEcCtD
Zidovudine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.018	CcSEcCtD
Zidovudine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.018	CcSEcCtD
Zidovudine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0163	CcSEcCtD
Zidovudine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0162	CcSEcCtD
Zidovudine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0156	CcSEcCtD
Zidovudine—TERT—embryo—amyotrophic lateral sclerosis	0.00331	0.167	CbGeAlD
Zidovudine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0154	CcSEcCtD
Zidovudine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0137	CcSEcCtD
Zidovudine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0132	CcSEcCtD
Zidovudine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0126	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0125	CcSEcCtD
Zidovudine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.012	CcSEcCtD
Zidovudine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00257	0.012	CcSEcCtD
Zidovudine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0118	CcSEcCtD
Zidovudine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0114	CcSEcCtD
Zidovudine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0113	CcSEcCtD
Zidovudine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0113	CcSEcCtD
Zidovudine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0111	CcSEcCtD
Zidovudine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0109	CcSEcCtD
Zidovudine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0105	CcSEcCtD
Zidovudine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0105	CcSEcCtD
Zidovudine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0105	CcSEcCtD
Zidovudine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0103	CcSEcCtD
Zidovudine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0102	CcSEcCtD
Zidovudine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0102	CcSEcCtD
Zidovudine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0101	CcSEcCtD
Zidovudine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0101	CcSEcCtD
Zidovudine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00214	0.01	CcSEcCtD
Zidovudine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00967	CcSEcCtD
Zidovudine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00964	CcSEcCtD
Zidovudine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00957	CcSEcCtD
Zidovudine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00952	CcSEcCtD
Zidovudine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00947	CcSEcCtD
Zidovudine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00945	CcSEcCtD
Zidovudine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00912	CcSEcCtD
Zidovudine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00895	CcSEcCtD
Zidovudine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00869	CcSEcCtD
Zidovudine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00865	CcSEcCtD
Zidovudine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00845	CcSEcCtD
Zidovudine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00839	CcSEcCtD
Zidovudine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00827	CcSEcCtD
Zidovudine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00824	CcSEcCtD
Zidovudine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00822	CcSEcCtD
Zidovudine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00815	CcSEcCtD
Zidovudine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00812	CcSEcCtD
Zidovudine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00807	CcSEcCtD
Zidovudine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00786	CcSEcCtD
Zidovudine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00779	CcSEcCtD
Zidovudine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00776	CcSEcCtD
Zidovudine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00767	CcSEcCtD
Zidovudine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00757	CcSEcCtD
Zidovudine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00754	CcSEcCtD
Zidovudine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00753	CcSEcCtD
Zidovudine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00751	CcSEcCtD
Zidovudine—TERT—nervous system—amyotrophic lateral sclerosis	0.00159	0.08	CbGeAlD
Zidovudine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00738	CcSEcCtD
Zidovudine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00732	CcSEcCtD
Zidovudine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00727	CcSEcCtD
Zidovudine—TERT—central nervous system—amyotrophic lateral sclerosis	0.00153	0.077	CbGeAlD
Zidovudine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00715	CcSEcCtD
Zidovudine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00715	CcSEcCtD
Zidovudine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00715	CcSEcCtD
Zidovudine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00712	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0071	CcSEcCtD
Zidovudine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00706	CcSEcCtD
Zidovudine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00691	CcSEcCtD
Zidovudine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00685	CcSEcCtD
Zidovudine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00685	CcSEcCtD
Zidovudine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00674	CcSEcCtD
Zidovudine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00672	CcSEcCtD
Zidovudine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00671	CcSEcCtD
Zidovudine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00665	CcSEcCtD
Zidovudine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00662	CcSEcCtD
Zidovudine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00653	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00624	CcSEcCtD
Zidovudine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0062	CcSEcCtD
Zidovudine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00615	CcSEcCtD
Zidovudine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00611	CcSEcCtD
Zidovudine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00609	CcSEcCtD
Zidovudine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00603	CcSEcCtD
Zidovudine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00595	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00591	CcSEcCtD
Zidovudine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00591	CcSEcCtD
Zidovudine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00586	CcSEcCtD
Zidovudine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00586	CcSEcCtD
Zidovudine—TERT—brain—amyotrophic lateral sclerosis	0.00121	0.0611	CbGeAlD
Zidovudine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00564	CcSEcCtD
Zidovudine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0056	CcSEcCtD
Zidovudine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00544	CcSEcCtD
Zidovudine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00541	CcSEcCtD
Zidovudine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00541	CcSEcCtD
Zidovudine—TK1—nervous system—amyotrophic lateral sclerosis	0.00109	0.055	CbGeAlD
Zidovudine—TK1—central nervous system—amyotrophic lateral sclerosis	0.00105	0.053	CbGeAlD
Zidovudine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00491	CcSEcCtD
Zidovudine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00485	CcSEcCtD
Zidovudine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000999	0.00469	CcSEcCtD
Zidovudine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000965	0.00453	CcSEcCtD
Zidovudine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00436	CcSEcCtD
Zidovudine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00432	CcSEcCtD
Zidovudine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000919	0.00431	CcSEcCtD
Zidovudine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00429	CcSEcCtD
Zidovudine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00407	CcSEcCtD
Zidovudine—SLC29A2—cerebellum—amyotrophic lateral sclerosis	0.00085	0.0428	CbGeAlD
Zidovudine—TK1—brain—amyotrophic lateral sclerosis	0.000835	0.0421	CbGeAlD
Zidovudine—SLC29A2—brain—amyotrophic lateral sclerosis	0.000691	0.0348	CbGeAlD
Zidovudine—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.000649	0.0327	CbGeAlD
Zidovudine—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.000459	0.0231	CbGeAlD
Zidovudine—SLC22A7—brain—amyotrophic lateral sclerosis	0.000444	0.0224	CbGeAlD
Zidovudine—SLC22A6—brain—amyotrophic lateral sclerosis	0.000428	0.0216	CbGeAlD
Zidovudine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000412	0.0207	CbGeAlD
Zidovudine—ABCC5—brain—amyotrophic lateral sclerosis	0.000373	0.0188	CbGeAlD
Zidovudine—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000338	0.017	CbGeAlD
Zidovudine—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.000336	0.0169	CbGeAlD
Zidovudine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000334	0.0168	CbGeAlD
Zidovudine—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000326	0.0164	CbGeAlD
Zidovudine—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000323	0.0163	CbGeAlD
Zidovudine—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000318	0.016	CbGeAlD
Zidovudine—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000283	0.0143	CbGeAlD
Zidovudine—ALB—brain—amyotrophic lateral sclerosis	0.000267	0.0135	CbGeAlD
Zidovudine—ABCC4—brain—amyotrophic lateral sclerosis	0.000259	0.013	CbGeAlD
Zidovudine—SLC22A8—brain—amyotrophic lateral sclerosis	0.000256	0.0129	CbGeAlD
Zidovudine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000245	0.0124	CbGeAlD
Zidovudine—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000225	0.0113	CbGeAlD
Zidovudine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000188	0.00945	CbGeAlD
Zidovudine—ABCG2—brain—amyotrophic lateral sclerosis	0.000182	0.00919	CbGeAlD
Zidovudine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000166	0.00838	CbGeAlD
Zidovudine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00016	0.00807	CbGeAlD
Zidovudine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000157	0.00789	CbGeAlD
Zidovudine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00014	0.00704	CbGeAlD
Zidovudine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000118	0.00593	CbGeAlD
Zidovudine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000113	0.00571	CbGeAlD
Zidovudine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000111	0.00558	CbGeAlD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00011	0.00114	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000109	0.00113	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000109	0.00113	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000109	0.00113	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000109	0.00113	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000108	0.00112	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000108	0.00112	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000107	0.00111	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000106	0.0011	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.00109	CbGpPWpGaD
Zidovudine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000104	0.00108	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000104	0.00108	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000104	0.00108	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000104	0.00108	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000104	0.00108	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000103	0.00107	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000103	0.00107	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000103	0.00107	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000103	0.00107	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000101	0.00105	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0001	0.00104	CbGpPWpGaD
Zidovudine—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	9.95e-05	0.00103	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	9.94e-05	0.00103	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.87e-05	0.00103	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.73e-05	0.00101	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	9.62e-05	0.001	CbGpPWpGaD
Zidovudine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.51e-05	0.000989	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	9.48e-05	0.000986	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	9.43e-05	0.000981	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	9.42e-05	0.00098	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	9.42e-05	0.00098	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.4e-05	0.000978	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	9.39e-05	0.000976	CbGpPWpGaD
Zidovudine—TERT—Disease—APOE—amyotrophic lateral sclerosis	9.34e-05	0.000971	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.19e-05	0.000956	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.19e-05	0.000956	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	9.17e-05	0.000953	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.1e-05	0.000946	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.1e-05	0.000946	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.07e-05	0.000943	CbGpPWpGaD
Zidovudine—ABCB1—brain—amyotrophic lateral sclerosis	9e-05	0.00453	CbGeAlD
Zidovudine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.82e-05	0.000917	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.73e-05	0.000907	CbGpPWpGaD
Zidovudine—TK1—Metabolism—APOE—amyotrophic lateral sclerosis	8.65e-05	0.000899	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.62e-05	0.000896	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	8.54e-05	0.000888	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	8.47e-05	0.000881	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.45e-05	0.000879	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.4e-05	0.000873	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	8.29e-05	0.000862	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.29e-05	0.000862	CbGpPWpGaD
Zidovudine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.28e-05	0.000861	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	8.24e-05	0.000857	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.2e-05	0.000853	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.19e-05	0.000852	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.11e-05	0.000843	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.01e-05	0.000833	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	7.97e-05	0.000829	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.95e-05	0.000826	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.92e-05	0.000823	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.87e-05	0.000819	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	7.71e-05	0.000801	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	7.68e-05	0.000799	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	7.6e-05	0.000791	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.53e-05	0.000783	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	7.5e-05	0.00078	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.5e-05	0.000779	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	7.46e-05	0.000776	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—amyotrophic lateral sclerosis	7.42e-05	0.000772	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	7.42e-05	0.000771	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	7.39e-05	0.000769	CbGpPWpGaD
Zidovudine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.39e-05	0.000769	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	7.15e-05	0.000744	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.07e-05	0.000735	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.02e-05	0.00073	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	7e-05	0.000728	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.83e-05	0.000711	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	6.81e-05	0.000708	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.74e-05	0.000701	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.67e-05	0.000694	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	6.56e-05	0.000682	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.54e-05	0.00068	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	6.48e-05	0.000673	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.44e-05	0.00067	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	6.43e-05	0.000669	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	6.43e-05	0.000669	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.42e-05	0.000668	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	6.4e-05	0.000665	CbGpPWpGaD
Zidovudine—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	6.4e-05	0.000665	CbGpPWpGaD
Zidovudine—TERT—Disease—PTGS2—amyotrophic lateral sclerosis	6.4e-05	0.000665	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	6.29e-05	0.000654	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	6.28e-05	0.000653	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	6.24e-05	0.000649	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	6.21e-05	0.000645	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	6.18e-05	0.000643	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	6.16e-05	0.000641	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6e-05	0.000624	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.99e-05	0.000623	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.97e-05	0.00062	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.92e-05	0.000616	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	5.89e-05	0.000612	CbGpPWpGaD
Zidovudine—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	5.85e-05	0.000608	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.85e-05	0.000608	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.74e-05	0.000597	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.74e-05	0.000597	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.68e-05	0.000591	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.67e-05	0.00059	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.67e-05	0.00059	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.62e-05	0.000585	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.61e-05	0.000583	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.61e-05	0.000583	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	5.56e-05	0.000578	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	5.54e-05	0.000576	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.47e-05	0.000569	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.44e-05	0.000566	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.4e-05	0.000562	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.36e-05	0.000557	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	5.31e-05	0.000552	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	5.25e-05	0.000546	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	5.24e-05	0.000545	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	5.24e-05	0.000545	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	5.24e-05	0.000545	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	5.19e-05	0.00054	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.16e-05	0.000537	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	5.14e-05	0.000535	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.13e-05	0.000533	CbGpPWpGaD
Zidovudine—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	5.11e-05	0.000532	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.06e-05	0.000526	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.97e-05	0.000517	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.97e-05	0.000517	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.88e-05	0.000508	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.88e-05	0.000508	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.86e-05	0.000506	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.79e-05	0.000498	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.77e-05	0.000496	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	4.76e-05	0.000495	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	4.65e-05	0.000484	CbGpPWpGaD
Zidovudine—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.63e-05	0.000481	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.59e-05	0.000477	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.55e-05	0.000473	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.51e-05	0.000469	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.48e-05	0.000466	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.45e-05	0.000463	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.45e-05	0.000462	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.43e-05	0.000461	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.31e-05	0.000448	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.27e-05	0.000444	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.26e-05	0.000443	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.2e-05	0.000437	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.19e-05	0.000435	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.18e-05	0.000435	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.16e-05	0.000432	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.15e-05	0.000432	CbGpPWpGaD
Zidovudine—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	4.11e-05	0.000427	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	4.05e-05	0.000421	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.93e-05	0.000409	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.91e-05	0.000407	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.79e-05	0.000394	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.61e-05	0.000375	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.53e-05	0.000367	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	3.53e-05	0.000367	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.51e-05	0.000365	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.49e-05	0.000362	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.45e-05	0.000359	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.45e-05	0.000359	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	3.44e-05	0.000358	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.36e-05	0.000349	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	3.25e-05	0.000338	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.24e-05	0.000337	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.24e-05	0.000336	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.24e-05	0.000336	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.18e-05	0.00033	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.16e-05	0.000328	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.15e-05	0.000327	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.08e-05	0.000321	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.07e-05	0.000319	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.96e-05	0.000308	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.000306	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.94e-05	0.000305	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.9e-05	0.000302	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.87e-05	0.000298	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.83e-05	0.000295	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	2.82e-05	0.000293	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.79e-05	0.00029	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.76e-05	0.000287	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.75e-05	0.000285	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.67e-05	0.000278	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.67e-05	0.000277	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.66e-05	0.000276	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.65e-05	0.000275	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.64e-05	0.000275	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	2.54e-05	0.000264	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.5e-05	0.00026	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.44e-05	0.000254	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.42e-05	0.000252	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000251	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	2.4e-05	0.00025	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.38e-05	0.000248	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.36e-05	0.000245	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.33e-05	0.000242	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.31e-05	0.000241	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.29e-05	0.000238	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.2e-05	0.000229	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.18e-05	0.000226	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.17e-05	0.000226	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	0.000221	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.1e-05	0.000219	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.1e-05	0.000219	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.07e-05	0.000216	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.98e-05	0.000206	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.93e-05	0.000201	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.89e-05	0.000197	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.75e-05	0.000182	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.75e-05	0.000182	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.74e-05	0.000181	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.73e-05	0.00018	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.67e-05	0.000174	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.66e-05	0.000173	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000165	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.49e-05	0.000155	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.44e-05	0.000149	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.44e-05	0.000149	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.43e-05	0.000149	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.43e-05	0.000148	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.36e-05	0.000141	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000137	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	0.000136	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.28e-05	0.000133	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.00013	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.2e-05	0.000125	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	0.000123	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.18e-05	0.000122	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	0.000122	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.00012	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.000113	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.09e-05	0.000113	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.09e-05	0.000113	CbGpPWpGaD
Zidovudine—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.08e-05	0.000112	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.000112	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	9.69e-06	0.000101	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	9.46e-06	9.84e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	8.84e-06	9.19e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.71e-06	8.02e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.44e-06	7.74e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.4e-06	7.69e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.08e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.64e-06	6.91e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.48e-06	6.74e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.05e-06	6.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.83e-06	6.06e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.99e-06	4.15e-05	CbGpPWpGaD
